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There has always been an intimate
relationship between medicine and
biology. Experiments in the 19th
century identified infectious agents
as the source of disease, discovered
sterile techniques for surgery and
developed effective anaesthetics. I’m
lucky they did: I can sit and type this
article five days after my angry
appendix and I parted ways in a
Seattle operating room. In 1850 I
wouldn’t have heard the soil raining
down on my coffin.
Others are not so lucky. Five
years ago my father died of
metastases from esophageal cancer,
and three months ago AIDS carried
off my dear friend Mark Miller. For
both, the best of modern medical
science bought them perhaps a year.
Why do these diseases still
confound 20th century biology,
despite all our progress? In part, as
Tony James argued so eloquently in
this space, we are slowed by our
inability to tackle problems
collaboratively, rather than as an
enormous number of competing
independent research groups. 
But reading a little about the 19th
century shows that this cannot be the
only factor slowing the development
of a brave new medicine. Pasteur was
certainly a hero, driven to the point
of ruining his own health in his
search for cures for infectious
diseases, but he was no angel of
collaborative science. He competed
vigorously and ruthlessly with others
for results and reputation, and he
conducted human experiments that
lay at the very border of his time’s
medical ethics, and far beyond ours.
So why can’t we make dramatic
advances like those of the 19th
century? The obvious answer (which
we use as our excuse to a public
hungry for progress) is that Pasteur,
Koch, Lister, Fleming, et al. solved
the easy problems and left the hard
ones to us. This is irrefutable. There
are many more differences between
our cells and those of a bacterial
pathogen than between a normal and
a malignant human cell.
But there are other causes we talk
about less willingly. One is the
explosion of information that makes it
almost impossible for anyone to know
about all of the medicine, biology and
chemistry relating to a single disease,
let alone all diseases. Pasteur’s
contributions spanned the whole of
science. He invented stereochemistry,
disproved spontaneous generation,
and developed safe vaccines for
human and animal diseases. His work
required an understanding of a wide
range of scientific disciplines, not just
an awareness of the known facts. 
I think part of our current problem
is a fundamental confusion between
facts and ways of manipulating them
in our minds. The facts are the data;
the ways of manipulating them are
described by words like interpretation
and understanding. In the past it has
been so hard to determine the facts of
biology that we haven’t thought much
about the process by which successful
biologists convert facts into under-
standing. But modern biology and
chemistry are now generating such
huge streams of data that our trad-
itional misty methods of turning small
numbers of facts into knowledge
seem certain to be overwhelmed. We
need a revolution in thinking about
thinking about biology before, for
example, pharmacology can really
form the interface between genomics
and combinatorial chemistry. 
Our intellectual difficulties make
us retreat into simplistic solutions for
the very problems (above) that we
talk of as complex. The suggestion
that we can cure cancer by putting a
wild-type p53 gene in every
malignant cell sounds as plausible to
me as the 1930s political dream of
solving the great depression by
putting a chicken in every pot.
The offering of simple solutions
for complex problems is in part
influenced by venture capital. At a
recent symposium on genetic models
for human disease, though some
talks were fine, others were largely
data-free appeals for commercial
funding. Does practical research
have to be done this way? The
British government’s response to the
need for an accurate method to
determine longitude (in the 18th
century) was to create a prize for the
first affordable, effective solution,
and give financial help to
competitors with promising initial
data. Perhaps it would work again.
The final reason for our failure to
make effective progress on medical
problems is the hardest to account
for: the feeling that applied research
is in some way inferior to basic
research. This attitude is rooted in a
fundamental prejudice that the most
abstract research area is the most
difficult and most noble. Most
biologists think that physicists are
smarter than biologists, for example.
Within biology, applied research has
been equated with biotechnology,
and has suffered in the debates
between those too pure to sully their
hands with industrial money and
those accused of sleeping with the
enemy for financial gain. Although
many of those who initially appeared
to be purists can now be found on
the advisory boards of companies,
the prejudice against applied
research lingers like a long and
painful hangover. Perhaps the
current (and to me equally
wrongheaded) belief that there are
no interesting problems left in
biology will convince more people to
try and emulate Pasteur by
combining the basic and applied
aspects of biology to tackle real and
pressing practical problems. 
Address: Departments of Physiology and
Biochemistry and Biophysics, University of
California, San Francisco, California, USA.
R1
Magazine
